Method and Therapeutic Use of PIGN and Other Genes or Gene Products That PIGN Interacts With for Prognosis and Treatment of Hematological Neoplasias

摘要

The invention provides a method for determining the level of risk for development or progression of a hematologic neoplasia in a subject by analyzing the level of a phosphatidylinositol glycan anchor biosynthesis protein, and providing an appropriate treatment or preventive measure, on the basis of this risk.